Find Federal Grants
National Institutes of Health · PAR-20-106
National Institutes of Health · PAR-20-107
FY2020 U.S. Embassy Promoting Study-in-the-United-States and Fostering English Language Learning Programs
U.S. Mission to Japan · TOKYO-PAS-FY20-02-07
FY2020 U.S. Embassy Tokyo: U.S.-Japan-Korea Trilateral English Language Student Exchange
U.S. Mission to Japan · TOKYO-PAS-FY20-02-04
U.S. Mission to Japan · TOKYO-PAS-FY20-02-01
U.S. Mission to Japan · TOKYO-PAS-FY20-02-02
U.S. Mission to Japan · TOKYO-PAS-FY20-02-09
U.S. Mission to Japan · TOKYO-PAS-FY20-02-11
U.S. Mission to Japan · TOKYO-PAS-FY20-02-06
Office of Postsecondary Education (OPE): Training Program for Federal TRIO Programs CFDA Number 84.103A
Department of Education · ED-GRANTS-013120-001
Dwight David Eisenhower Transportation Fellowship Program (DDETFP) Graduate Fellowship
DOT Federal Highway Administration · 693JJ318NF5227-2020
Office of Postsecondary Education (OPE): Alaska Native and Native Hawaiian-Serving Institutions (ANNH) Program CFDA Number 84.031W (Native Hawaiian)
Department of Education · ED-GRANTS-013020-002
Office of Postsecondary Education (OPE): Alaska Native and Native Hawaiian-Serving Institutions (ANNH) Program CFDA Number 84.031N (Alaska Native)
Department of Education · ED-GRANTS-013020-001
Office of Postsecondary Education (OPE): Asian American and Native American Pacific Islander-Serving Institutions (AANAPISI) Program CFDA Number 84.031L
Department of Education · ED-GRANTS-012820-001
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
National Institutes of Health · PAR-20-077
U.S. Mission to Morocco · PAS-MOROCCO-FY20-02
Office of Elementary and Secondary Education (OESE): Expanding Opportunity Through Quality Charter Schools Program (CSP): Grants to State Entities CFDA Number 84.282A
Department of Education · ED-GRANTS-012720-001
Administration of the Dwight David Eisenhower Transportation Fellowship Program (DDETFP) Local Competition at Designated Institutions of Higher Education
DOT Federal Highway Administration · 693JJ318NF5228-2020
HEAL Initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-20-031
Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
National Institutes of Health · PAR-20-092